KPIs & Operating Metrics(New)
Growth Metrics

Amgen (AMGN) Deferred Taxes (2016 - 2026)

Amgen has reported Deferred Taxes over the past 14 years, most recently at -$176.0 million for Q1 2026.

  • For Q1 2026, Deferred Taxes rose 29.6% year-over-year to -$176.0 million; the TTM value through Mar 2026 reached -$647.0 million, up 39.93%, while the annual FY2025 figure was -$721.0 million, 41.29% up from the prior year.
  • Deferred Taxes for Q1 2026 was -$176.0 million at Amgen, down from -$19.0 million in the prior quarter.
  • Over five years, Deferred Taxes peaked at -$19.0 million in Q4 2025 and troughed at -$623.0 million in Q4 2023.
  • A 5-year average of -$270.4 million and a median of -$263.0 million in 2022 define the central range for Deferred Taxes.
  • Biggest five-year swings in Deferred Taxes: tumbled 718.37% in 2024 and later surged 94.31% in 2025.
  • Year by year, Deferred Taxes stood at -$351.0 million in 2022, then crashed by 77.49% to -$623.0 million in 2023, then soared by 46.39% to -$334.0 million in 2024, then surged by 94.31% to -$19.0 million in 2025, then crashed by 826.32% to -$176.0 million in 2026.
  • Business Quant data shows Deferred Taxes for AMGN at -$176.0 million in Q1 2026, -$19.0 million in Q4 2025, and -$30.0 million in Q3 2025.